High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes

Thanitsara Rittiphairoj; Louis Leslie; Jean-Pierre Oberste; Tsz Wing Yim; Gregory Tung; Lisa Bero; Paula Riggs; Kent E. Hutchison; Jonathan M. Samet; Tianjing Li

doi:10.7326/annals-24-03819

August 25, 2025Annals of Internal Medicine

High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes

View Full Paper

Ask AI

Bookmark

Share

Key Points

High-concentration THC cannabis products are becoming more common, impacting mental health outcomes significantly.
Research shows that increased THC levels may correlate with various mental health issues like anxiety and paranoia.
This observational analysis draws from the evolving cannabis market trends and their effects on mental health.
Findings highlight the need for further scrutiny of cannabis use as it may influence mental health risks.

Implication

Observational analysis links high-concentration THC products to mental health outcomes, suggesting caution in use.

Abstract

Rapid changes in the legalized cannabis market have led to the predominance of high-concentration delta-9-tetrahydrocannabinol (THC) cannabis products.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rittiphairoj et al. (2025) studied this question.

synapsesocial.com/papers/68c19f9154b1d3bfb60db076 https://doi.org/10.7326/annals-24-03819

View Full Paper

Ask AI

Bookmark

Share

High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes

Key Points

Implication

Abstract

Discussion

Cite This Study

High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading